Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 27 3
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 10 1
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/14/2021 37 37
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 72 13
Fluoxetine  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 3 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/09/2020 21 11
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/26/2020 22 11
Atazanavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 6 1
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 5 1
Sertraline  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020 2 0